As COSCIENS Biopharma Inc. prepares for its upcoming earnings report, investors are closely watching to see if the company can continue its recent successes in the volatile biopharma sector.
Scheduled for release after the market closes on August 13, 2026, COSCIENS Biopharma Inc. will share its financial results for the fiscal period ending June 30, 2026. With a history of mixed earnings surprises, this report comes at a time of changing market dynamics and recent corporate developments that could affect how investors feel about the stock.
Recent earnings trend
Advertisement
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeAdvertisement
Market cap
$7.70M
52W high
$14.80
52W low
$1.10
1W change
+7.32%
Beta
1.89
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
573.8%
Annualized
90-Day Vol
346.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.09 | C$1.12 – C$58.56 |
| 60 trading days | C$8.58 | C$0.52 – C$141.11 |
| 90 trading days | C$9.11 | C$0.30 – C$280.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: Limited — historical beat/miss data exists for 64 quarter(s), but no upcoming consensus.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | -0.9563 | — | — |
| 2025-09-30 | 2025-11-11 | -0.7885 | — | — |
| 2025-06-30 | 2025-08-12 | -1.1773 | — | — |
| 2025-03-31 | 2025-05-13 | -3.0027 | — | — |
| 2024-09-30 | 2024-11-11 | -2.5268 | — | — |
| 2024-06-30 | 2024-08-13 | -0.8763 | — | — |
Advertisement
Investor takeaway: While COSCIENS has managed to exceed expectations in the past, the lack of consensus estimates for this report creates some uncertainty. Investors should look at the company's historical performance as they consider how it might impact the stock price.
Bull case
If COSCIENS can effectively leverage its recent strategic initiatives and improve its financial metrics, it may pleasantly surprise investors, reinforcing its growth path and boosting market confidence.
Bear case
On the flip side, given the company's mixed earnings history and the absence of clear consensus estimates, there is a risk that the upcoming report may disappoint. This could lead to further declines in investor sentiment and stock price.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
